Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Clinical trial NCT01008150 · COMPLETED
Trial details
- NCT number
- NCT01008150
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2015-09-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.